• Chromium supplementation does not improve glucose tolerance, insulin sensitivity...
  Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance: response to Gunton et al.

  Diabetes Care. 2005 Jul ;28(7):1841-2; author reply 1842-3.
  PubMed
• Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a n...
  Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.

  Arch Intern Med. 2005 Jun 27 ;165(12):1430-5.
  PubMed
• Effects of different blood pressure-lowering regimens on major cardiovascular ev...
  Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.

  Arch Intern Med. 2005 Jun 27 ;165(12):1410-9.
  PubMed
• Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fas...
  Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  Arch Intern Med. 2005 Jun 27 ;165(12):1401-9.
  PubMed
• Modest salt reduction reduces blood pressure and urine protein excretion in blac...
  Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial.

  Hypertension. 2005 Aug ;46(2):308-12. Epub 2005 Jun 27 .
  PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on